Mesolimbic and striatal dopamine receptor supersensitivity: Prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG)
- 1 March 1985
- Vol. 6 (2) , 179-183
- https://doi.org/10.1016/0196-9781(85)90036-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to ratsNeuropharmacology, 1984
- Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brainPharmacological Research Communications, 1983
- CNS putative L-prolyl-L-leucyl-glycinamide (PLG) receptors, brain and lymphocyte dopamine receptorsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-GlycinamideScience, 1981
- The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the ratLife Sciences, 1981
- Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindingsPeptides, 1981
- Inhibition of neuroleptic-induced dopamine receptor supersensitivity by cyclo (Leu-Gly)Pharmacology Biochemistry and Behavior, 1980
- Changes in rat striatal dopamine turnover and receptor activity during one years neurolepticEuropean Journal of Pharmacology, 1980
- In Search of Treatment for Tardive Dyskinesia: Review of the Literature*Schizophrenia Bulletin, 1979
- LITHIUM AND M.R.I.H. IN TARDIVE DYSKINESIAThe Lancet, 1974